Topotecan in small cell lung cancer

被引：0
|
作者：
Schiller, JH [1 ]
机构：
[1] Univ Wisconsin, Ctr Comprehens Canc, Dept Med, Madison, WI 53792 USA
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S27 / S33
页数：7
相关论文
共 50 条
  • [31] Topotecan in the treatment of elderly patients with relapsed small-cell lung cancer
    Garst, Jennifer
    Buller, Richard
    Lane, Stephen
    Crawford, Jeffrey
    CLINICAL LUNG CANCER, 2005, 7 (03) : 190 - 196
  • [32] Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer A Randomized Clinical Trial
    Takahashi, Nobuyuki
    Hao, Zhonglin
    Villaruz, Liza C.
    Zhang, Jun
    Ruiz, Jimmy
    Petty, W. Jeffrey
    Mamdani, Hirva
    Riess, Jonathan W.
    Nieva, Jorge
    Pachecho, Jose M.
    Fuld, Alexander D.
    Shum, Elaine
    Chauhan, Aman
    Nichols, Samantha
    Shimellis, Hirity
    Mcglone, Jessie
    Sciuto, Linda
    Pinkiert, Danielle
    Graham, Chante
    Shelat, Meenakshi
    Kattappuram, Robbie
    Abel, Melissa
    Schroeder, Brett
    Upadhyay, Deep
    Krishnamurthy, Manan
    Sharma, Ajit Kumar
    Kumar, Rajesh
    Malin, Justin
    Schultz, Christopher W.
    Goyal, Shubhank
    Redon, Christophe E.
    Pommier, Yves
    Aladjem, Mirit I.
    Gore, Steven D.
    Steinberg, Seth M.
    Vilimas, Rasa
    Desai, Parth
    Thomas, Anish
    JAMA ONCOLOGY, 2023, 9 (12) : 1669 - 1677
  • [33] Topotecan is an effective treatment for small cell lung cancer (SCLC) in clinical routine use
    Fink, T
    Kaubitzsch, S
    Ficker, J
    LUNG CANCER, 2005, 49 : S318 - S318
  • [34] The efficacy of apatinib plus topotecan as laterline therapy for advanced small cell lung cancer
    Qin, H.
    Wang, F.
    Wang, S. S.
    Zeng, Z.
    Gao, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S1043 - S1043
  • [35] Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer
    Se Hoon Park
    Eun Kyung Cho
    Yujin Kim
    Sun Young Kyung
    Chang Hyeok An
    Sang Pyo Lee
    Jeong Woong Park
    Sung Hwan Jeong
    Jae-Ik Lee
    Soo Jin Choi
    Jinny Park
    Dong Bok Shin
    Jae Hoon Lee
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 1009 - 1014
  • [36] Phase II trial of docetaxel and topotecan in recurrent and extensive small cell lung cancer
    Gormley, N
    Edelman, MJ
    Smith, R
    Hausner, PF
    Bedor, M
    Bisaccia, S
    LUNG CANCER, 2004, 46 : S42 - S43
  • [37] A pilot study of topotecan in patients with irinotecan-refractory small cell lung cancer
    Kim, Y. S.
    Hong, J.
    Park, S. H.
    Park, J.
    Cho, E. K.
    Shin, D. B.
    Lee, J. H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 388 - 388
  • [38] Phase II study of topotecan in refractory and sensitive small cell lung cancer (SCLC)
    Ardizzoni, A
    Hansen, HH
    Dombernowsky, P
    Kaplan, S
    Postmus, PE
    Gamucci, T
    Schaefer, B
    Wanders, J
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 84 - 84
  • [39] Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status
    Treat, J
    Huang, CH
    Lane, SR
    Levin, J
    ONCOLOGIST, 2004, 9 (02): : 173 - 181
  • [40] Phase II Study of Topotecan with Cisplatin in Japanese Patients with Small Cell Lung Cancer
    Hosomi, Yukio
    Shibuya, Masahiko
    Niho, Seiji
    Ichinose, Yukito
    Kiura, Katsuyuki
    Sakai, Hiroshi
    Takeda, Koji
    Kudo, Shinzo
    Eguchi, Kenji
    Matsui, Kaoru
    Masuda, Noriyuki
    Ando, Masahiro
    Watanabe, Koshiro
    ANTICANCER RESEARCH, 2011, 31 (10) : 3449 - 3456
12345